Han Zhu

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Wanhong Zhao, Baiyan Wang, Lijuan Chen et al. · Journal of Hematology & Oncology · 2022 · 142 citations · Full text

Medicine, Hematology, Pharmacology +14

The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia

Huihui Zhao, Huayuan Zhu, Jiayu Huang et al. · Leukemia Research · 2018 · 110 citations

Medicine, Oncology, Pharmacology +10

Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy

Lina Zhang, Shuai Wang, Ji Xu et al. · Experimental Hematology and Oncology · 2021 · 58 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study

Han Zhu, Lulu Yang, Bin Zhou et al. · Carcinogenesis · 2006 · 57 citations

Life Sciences, Genetics, Oncology +16

Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines.

Jianping Mao, Shan Li, Huihui Zhao et al. · PubMed · 2018 · 36 citations · Full text

Medicine, Oncology, Pharmacology +15